A proposal to deregulate AI products used in health care would shift the burden of vetting those tools onto health systems.

Several pharmaceutical companies that struck drug pricing deals with the White House said they're exempt from the Medicare ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

The health sector is working to navigate what could be the most significant changes to the U.S. vaccine program in decades.

Since his first term, Trump has promised to lower U.S. drug prices to levels charged in other rich countries. On Friday, the ...

The choice that one person makes not to vaccinate has real costs — financial and otherwise — for their neighbors.

Under a rule proposed by the Trump administration, pharma companies and pharmacy benefit managers will still not have to post ...

Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to ...

Federal agencies that used to set up guardrails for health technology have transformed into cheerleaders for new risky technologies like AI.

Good morning, Pharmalittle readers. This is Allison DeAngelis, filling in for Mr. Pharmalot. Today’s newsletter is brought to you by the dark roast Keurig pods I brought with me on my holiday travels.

Read the conversation that Nalis had with Morgentaler to learn how testosterone originally fell out of favor in medicine, how it came back, and what a castrated lizard had to do with it all. FDA ...

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...